Back to Search
TODD RICH, MD
MD
Internal Medicine Physician
NPI: 1578594388Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
35038320(OH)
Research & Publications (20)
Development of a high-throughput assay for monitoring cAMP levels in cardiac ventricular myocytes.
PMID 19247193·J Cardiovasc Pharmacol·2009
7-preclinical
Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities.
PMID 19166244·Technol Cancer Res Treat·2009
8-other
Optimizing standard patient management through order sets - impact on care (blood cultures).
PMID 19380981·Stud Health Technol Inform·2009
8-other
Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers.
PMID 19463265·Pharmacol Biochem Behav·2009
7-preclinical
Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
PMID 19642177·Cancer·2009
8-other
PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.
PMID 19261859·Proc Natl Acad Sci U S A·2009
7-preclinical
Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
PMID 19017755·J Clin Endocrinol Metab·2009
5-case
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.
PMID 19139424·J Clin Oncol·2009
4-observational
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
PMID 19636002·J Clin Oncol·2009
3-trial
Adenovirus type 5 E4 Orf3 protein targets promyelocytic leukaemia (PML) protein nuclear domains for disruption via a sequence in PML isoform II that is predicted as a protein interaction site by bioinformatic analysis.
PMID 19088278·J Gen Virol·2009
8-other
PML: a tumor suppressor that regulates cell fate in mammary gland.
PMID 19652541·Cell Cycle·2009
6-review
Roles of GRK and PDE4 activities in the regulation of beta2 adrenergic signaling.
PMID 18347080·J Gen Physiol·2008
8-other
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma.
PMID 19259306·Gastrointest Cancer Res·2008
8-other
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
PMID 18430910·JAMA·2008
3-trial
A novel von Hippel-Lindau point mutation presents as apparently sporadic pheochromocytoma.
PMID 18584357·Cancer Invest·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE
CLEVELAND, OH 44195 - Phone
- (800) 223-2273
Quick Facts
- NPI
- 1578594388
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile